Article Name Interaction
The FDA approval of Thermo Fisher’s Oncomine Dx Express Test marks a key advancement in precision oncology, enabling fast, accurate detection of EGFR exon 20 insertion mutations and guiding NSCLC patients to targeted treatments like ZEGFROVY.
17th July, 2025
The CE Mark approval of the VitalFlow™ ECMO System marks a significant advancement in extracorporeal life support, delivering enhanced precision and control for managing critically ill cardiac and respiratory patients.
15th July, 2025
World-first deployment of AI-powered laser tech enhances medication safety in high-risk hospital settings
10th July, 2025
Highlighting key cybersecurity challenges and readiness gaps across the evolving medical device ecosystem.
07th July, 2025
CE Mark Approval Advances Precision Thrombectomy with Vessel-Conforming Design for Improved Stroke Outcomes Across Europe
02nd July, 2025
Next-gen GLP-1 therapies and real-time biosensors are redefining metabolic care—delivering effective weight loss while preserving muscle mass, and enabling more personalized, outcome-focused treatment.
01st July, 2025
New app rollout enhances insulin automation and real-time glucose monitoring through seamless smartphone control.
25th June, 2025
World Economic Forum recognizes INBRAIN for its groundbreaking graphene-based brain-computer interface platform aimed at treating neurological disorders with unmatched precision.
25th June, 2025
The first-in-human use of the Sola™ Coronary Laser IVL System marks a breakthrough in coronary calcium modification, providing physicians with a novel level of precision and control in treating complex calcified lesions.
20th June, 2025
The launch of Ruby® XL represents a breakthrough in vascular embolization, offering physicians unprecedented flexibility and efficiency for complex case management.
17th June, 2025
With over 50,000 successful uses and backing from the Serum Institute, IntegriMedical’s N-FIS system is redefining patient comfort and safety as it expands from paediatrics to gynaecology.
12th June, 2025
Groundbreaking non-active implant for acid reflux draws global attention and fuels U.S. clinical engagement at world’s premier GI conference.
27th May, 2025
In an exclusive interview with MedTech Spectrum, Shalin Patel, CEO of Dräger – Asia Pacific, shares insights on redefining anaesthesia care with advanced ventilation systems, green technologies, and data-driven solutions.
21st April, 2025
Jason Hoffe, VP of APAC Vision Care at Alcon, discusses unmet needs, groundbreaking advancements, and the company’s commitment to transforming eye care across Asia-Pacific
03rd January, 2025
In a significant move towards the growth of the healthcare technology sector in India, Ireland-headquartered Medtronic had announced an investment of approximately Rs 3000 crore, earlier this year, to expand the Medtronic Engineering & Innovation Center (MEIC) in Hyderabad. MEIC is Medtronic’s largest research and development (R&D) centre outside of the US. In addition, Medtronic is supporting the Government of Telangana’s efforts to position Hyderabad as a global hub for healthcare technology research and innovation. In conversation with MedTech Spectrum & BioSpectrum, Divya Prakash Joshi, Vice President & MEIC Site Leader, Medtronic talks about the new investment and the future plans of MEIC.
23rd October, 2023
BioBank Japan, a hospital-based multi-institutional biobank that has collected DNA, serum and medical record information from ~260,000 patients affected by one of 51 pre-defined diseases, is now launching a new phase to accelerate precision medicine and health in Japan. In an address on May 24 in Tokyo, Professor Yoichiro Kamatani, a member of the Steering Committee at BioBank Japan, presented the new phase and future direction of this important biobank for the future health of Japan. In an interaction with BioSpectrum Asia, Prof. Kamatani reveals more details about the work being done at BioBank Japan.
07th July, 2023
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer